-
Anti-Cancer Drug Herceptin Associated With Significant Risk of Cardiotoxicity
Genentech Says Its Breast Cancer Drug Can Increase Risk of Heart Problems The FDA and Genentech, Inc. have warned healthcare professionals by means of an August 2005 "Dear Doctor" letter of study data linking…
-
Analyst Report Forecasts Some Choppy Waters for Return of Tysabri
FDA Adverse Event Reports Show Tysabri May Be Tied To Other Serious Side Effects On August 29, 2005 The Wall Street Journal ("WSJ") reported that a list of adverse event reports made to the…
-
Adderall: Health Canada Allows Shire’s ADHD Drug Back on Market
Sudden Cardiac Death and Stroke Case Reports Had Caused Health Canada to Recall Adderall in February 2005 Health Canada announced on August 24, 2005 that Adderall XR, an attention deficit hyperactivity disorder ("ADHD") drug,…
-
The Ernst Vioxx Verdict: A Retrospective Look Into the Jury Room, Part Three
The Ernst v. Merck Jury: On Why Punitive Damages Were Warranted, and How They Arrived at the $229 Million Amount The Association of Trial Lawyers of America ("ATLA"), of which I am a proud…
-
The Ernst Vioxx Verdict: A Retrospective Look Into the Jury Room, Part Two
The Ernst v. Merck Jury: On Merck’s Decision to Market Vioxx Despite Knowing About the Cardiovascular Problems The Association of Trial Lawyers of America ("ATLA"), of which I am a proud member, has compiled…
-
The Ernst Vioxx Verdict: A Retrospective Look Into the Jury Room, Part One
The Ernst v. Merck Jury: On Sending a Message to Merck and Big Pharma The Association of Trial Lawyers of America ("ATLA"), of which I am a proud member, has compiled selected statements made…
